Understanding Breast Cancer Immunotherapy: A Simple Guide for Patients

If you or someone you love has breast cancer, you might have heard the word immunotherapy. Your doctor may have even mentioned it during a clinic visit. This modern treatment approach is new to many people and brings up plenty of questions.

Can it really help your body fight cancer? Let us break down this topic in clear, simple everyday words so you know what to expect and can talk comfortably with your medical team.

What Is Immunotherapy?

Simply put, immunotherapy is a medical treatment that helps your own body's disease-fighting immune system find and destroy cancer cells. Think of it as giving your body's internal military forces a special training program to recognize and attack dangerous enemy cells.

Right now, doctors mainly use this treatment for hard-to-treat cancer types that carry a higher risk of coming back or spreading to other parts of the body. This includes a type called triple-negative breast cancer. Researchers are also running clinical trials to see how well it works for other forms like HER2-positive and ER-positive breast cancers.

How Does This Treatment Work?

Imagine your immune system as a country's defense army. This army constantly searches for germs, viruses, and other foreign invaders to protect your health. However, cancer cells act like clever tricksters. Sometimes these abnormal cells wear disguises so your immune system fails to recognize them as a threat.

Immunotherapy helps solve this problem in two main ways:

1. Helping your body spot the enemy: Some immunotherapy drugs remove the disguises from cancer cells. This allows your immune system to see the threat clearly and launch an attack.

2. Making your defense forces stronger: Other medicines boost your immune system cells so they gain extra power to fight off cancer successfully.

Doctors divide these approaches into two main categories:

• Active immunotherapy: This method studies unique surface markers, known as antigens, on your breast cancer cells. It then trains your immune system to attack only those specific markers.
• Passive immunotherapy: This method uses laboratory-made medicines given to your body to enhance your natural cancer-fighting abilities.

What Medicines Are Used for Breast Cancer Immunotherapy?

Medical guidelines currently approve a couple of main immunotherapy medicines for treating specific breast cancer types.

1. Pembrolizumab (Keytruda): Doctors use this medicine for triple-negative breast cancer. The drug blocks a specific protein that cancer cells use to hide from your immune system. Because the protein is blocked, your immune system can easily spot and attack the cancer cells. Doctors sometimes give this medicine before and after surgery to help stop the cancer from returning. They also use it for cancer that has spread to other parts of the body or displays specific biomarker signs in its DNA.

2. Dostarlimab (Jemperli): Doctors use this medicine for breast cancers that return after other treatments and carry specific tumor marker features.

How Is Immunotherapy Given?

Doctors usually give this treatment through a needle in your vein as an intravenous infusion, much like receiving fluids in a hospital. Your treatment schedule depends on your personal health plan and the exact medicine you receive.

Most patients receive these infusions every three to six weeks. Depending on your medical needs, your care team might continue this treatment plan for several months or up to two years.

Let Us Talk About Side Effects

Just like any cancer treatment, immunotherapy can cause side effects. However, these side effects affect every person differently. Some people experience mild discomfort. This others notice very few changes at all. The most important rule is to tell your doctor right away if you feel unwell or notice new symptoms.

Let us look at common side effects and rare serious reactions:

How Successful Is This Treatment?

Immunotherapy represents an exciting and highly promising new field in cancer treatment. For patients facing challenging diagnoses like triple-negative breast cancer, this treatment has helped improve recovery rates and extend lives.

One major clinical study showed that patients who received pembrolizumab along with chemotherapy lived longer than patients who received chemotherapy alone.

Researchers around the world are currently running hundreds of clinical studies to test immunotherapy for other breast cancer types. This means medical science continues to improve this field every single day.

Take-Home Message

• Immunotherapy does not act like chemotherapy by directly killing cells. Instead, it stimulates your own immune system to fight the cancer.
• This treatment is especially valuable for triple-negative breast cancer.
• Like all treatments, it has side effects, but your care team can help you manage them safely.
• Immunotherapy offers great hope for the future as medical researchers continue their work.
• The best way to know if this treatment fits your health needs is to talk directly with your cancer specialist.

Sources and References:
1. American Cancer Society. Immunotherapy for Breast Cancer. Available from: cancer.org
2. National Cancer Institute (NCI). Immunotherapy to Treat Cancer. Available from: cancer.gov
3. Mayo Clinic. Breast Cancer Treatment: Immunotherapy Options. Available from: mayoclinic.org
4. NHS UK. Targeted Therapies and Immunotherapy. Available from: nhs.uk
5. Cleveland Clinic. Understanding Breast Cancer Immunotherapy and Side Effects. Available from: clevelandclinic.org